Steve E. Krognes - 04 Jun 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Reporting relationship: Director
Issuer ticker: GH
Reported as of: 04 Jun 2026
Net transaction value: -$1,231,522
SEC form: 4
Accepted by SEC: 05 Jun 2026, 19:50:28 UTC
Prior SEC filing: 05 Jun 2026
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John Saia, as attorney-in-fact for Steve Krognes

Filing notes and source

Key filing fact

Steve E. Krognes filed Form 4 for Guardant Health, Inc. (GH) on 05 Jun 2026.

Key facts

This page summarizes Steve E. Krognes's Form 4 filing for Guardant Health, Inc. (GH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 19:50.

Change

Previous filing in this sequence was filed on 05 Jun 2026.
Current net transaction value: -$1,231,522.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001666236 Primary reporting owner

Krognes Steve E.

Relationship: Director
Address: 3100 HANOVER STREET, PALO ALTO
Signature: /s/ John Saia, as attorney-in-fact for Steve Krognes
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Sale

Transaction value: -$1,231,522
Shares: -9,294
Change %: -48%
Price: $132.51
Shares after: 10,222
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.50 to $132.71. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.